Article
Hypofibrinolytic State in Subjects with Type 2 Diabetes Mellitus Aggravated by the Metabolic Syndrome before Clinical Manifestations of Atherothrombotic Disease.
BioMed research international - 1 Jan 2017
Aburto-Mejía Elsa, Santiago-Germán David, Martínez-Marino Manuel, María Eugenia Galván-Plata, Almeida-Gutiérrez Eduardo, López-Alarcón Mardia, Hernández-Juárez Jesús, Alvarado-Moreno Antonio, Leaños-Miranda Alfredo, Majluf-Cruz Abraham, Isordia-Salas Irma
Abstract excerpt
Background. Metabolic and genetic factors induce plasminogen activator inhibitor type-1 (PAI-1) overexpression; higher PAI-1 levels decrease fibrinolysis and promote atherothrombosis. Aim. To assess PAI-1 antigen levels among subjects with type 2 diabetes mellitus (T2DM) plus Metabolic Syndrome (MetS) before clinical manifestations of atherothrombosis and the contribution of metabolic factors and 4G/5G...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
